2026 NPPES data Infectious Disease Physician NPI 1336169028 MD, FACP, FIDSA
Verify on CMS →

REZHAN HUSSEIN, MD, FACP, FIDSA

Infectious Disease Physician in HERSHEY, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
393
Medicare Part D claims · 46 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
79%
generic claims · 21% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
71.7884/100
▼ 11 pts below national avg 83.1 · [object Object]

What the federal data shows

REZHAN HUSSEIN, MD, FACP, FIDSA reported a CMS MIPS final score of 71.7884/100 — below the 83.1 national average — and filed 393 Medicare Part D claims in 2023.

71.7884/100
MIPS score · -11 vs avg
393
Part D claims, 2023
79%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

REZHAN HUSSEIN, MD, FACP, FIDSA's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

72 9th percentile higher than 9% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

REZHAN HUSSEIN, MD, FACP, FIDSA practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about REZHAN HUSSEIN, MD, FACP, FIDSA?

Below national average

NPI registry status

Active

Issued 07/19/2006

NPI 1336169028

Primary specialty

Infectious Disease Physician

Mid-sized

8,292 US NPIs in this specialty

Medicare Part D claims

393 52% vs specialty avg

2023 prescription claims

Specialty avg: 816

MIPS final score

71.7884/100 11.311599999999999% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Infectious Disease Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Infectious Disease Physician share within Pennsylvania

1. Infectious Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Infectious Disease Physician share within Pennsylvania

Medicare quality performance — MIPS

REZHAN HUSSEIN, MD, FACP, FIDSA's 2023 MIPS final score plotted against the Infectious Disease Physician national average

Below national average
MIPS Final Score
71.7884/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Infectious Disease Physician) — 71.7884/100 vs national avg 83.1

0%100%National avg83%71.8%
MIPS final score (Infectious Disease Physician) — 71.7884/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

REZHAN HUSSEIN, MD, FACP, FIDSA appears in the CMS NPPES registry as a Infectious Disease Physician provider holding MD, FACP, FIDSA credentials at 500 UNIVERSITY DR, HERSHEY, PA, 17033, with a listed phone of (717) 531-8881. NPI 1336169028 was issued on 07/19/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HUSSEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 393 prescription claims written by this provider, covering 46 Medicare beneficiaries and totaling roughly $267K in drug spend, split 21% brand-name and 79% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 71.7884/100 for the 2023 performance year (Quality 48.3237, Cost 57.6377), compared with the national average of 83.1.

Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

500 UNIVERSITY DR
HERSHEY, PA 17033

Provider Details

NPI 1336169028
Specialty Infectious Disease Physician
Credentials MD, FACP, FIDSA
Gender Male
NPI Issued 07/19/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

71.7884
Final Score
Avg: 83.1
48.3237
Quality
57.6377
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where REZHAN HUSSEIN, MD, FACP, FIDSA bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

THE MILTON S HERSHEY MEDICAL CENTER PHYSICIANS GROUP
HERSHEY, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to REZHAN HUSSEIN, MD, FACP, FIDSA. To verify REZHAN HUSSEIN, MD, FACP, FIDSA's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

REZHAN HUSSEIN, MD, FACP, FIDSA — brand share 21.0%
Specialty average (est.)

21% brand-name claims vs 79% generic, on 393 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

393
Total Claims
$267K
Total Drug Cost
46
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
427
Total Day Supply
10,693
Brand vs Generic
21% brand / 79% generic
Brand Drug Cost
$239K
Generic Drug Cost
$28K
Antibiotic Claims
175

Patient Demographics

Average Patient Age
70.6 years
Avg HCC Risk Score
2.24
Gender Split
52% female / 48% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What REZHAN HUSSEIN, MD, FACP, FIDSA prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ethambutol Hcl
43
Azithromycin
41
Rifampin
31
Amoxicillin
21
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
18
Daptomycin
15
Abacavir
Abacavir Sulfate
12
Juluca
Dolutegravir/Rilpivirine
12
Lamivudine
12
Odefsey
Emtricitab/Rilpiviri/Tenof Ala
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Infectious Disease Physician Overview

How REZHAN HUSSEIN, MD, FACP, FIDSA fits within the Infectious Disease Physician landscape nationally.

8,292
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider

REZHAN HUSSEIN, MD, FACP, FIDSA's 393 claims are below the specialty average of 816.

Nearby Infectious Disease Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as HUSSEIN.

Compare Infectious Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is REZHAN HUSSEIN, MD, FACP, FIDSA's specialty?
REZHAN HUSSEIN, MD, FACP, FIDSA specializes in Infectious Disease Physician and practices in HERSHEY, Pennsylvania. Credentials: MD, FACP, FIDSA.
How much does REZHAN HUSSEIN, MD, FACP, FIDSA prescribe under Medicare Part D?
In 2023, REZHAN HUSSEIN, MD, FACP, FIDSA wrote 393 Medicare Part D claims totaling $267K in drug costs for 46 beneficiaries.
What is REZHAN HUSSEIN, MD, FACP, FIDSA's Medicare quality score?
REZHAN HUSSEIN, MD, FACP, FIDSA has a CMS MIPS Final Score of 71.7884/100 (Quality: 48.3237, Cost: 57.6377). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is REZHAN HUSSEIN, MD, FACP, FIDSA located?
REZHAN HUSSEIN, MD, FACP, FIDSA is located at 500 UNIVERSITY DR, HERSHEY, PA, 17033. Phone: (717) 531-8881.
What is REZHAN HUSSEIN, MD, FACP, FIDSA's NPI number?
REZHAN HUSSEIN, MD, FACP, FIDSA's National Provider Identifier (NPI) is 1336169028, issued on 07/19/2006.
Does REZHAN HUSSEIN, MD, FACP, FIDSA prescribe more brand-name or generic drugs?
REZHAN HUSSEIN, MD, FACP, FIDSA's prescribing is 21% brand-name and 79% generic drugs by claim count, with $239K in brand drug costs.
How many Infectious Disease Physician providers are there in the US?
There are 8,292 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does REZHAN HUSSEIN, MD, FACP, FIDSA prescribe most often?
Based on 2023 Medicare Part D data, REZHAN HUSSEIN, MD, FACP, FIDSA's most frequently prescribed drugs include Ethambutol Hcl, Azithromycin, Rifampin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does REZHAN HUSSEIN, MD, FACP, FIDSA accept Medicare?
REZHAN HUSSEIN, MD, FACP, FIDSA appears in CMS Medicare data with 393 Part D claims and 46 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify REZHAN HUSSEIN, MD, FACP, FIDSA's credentials?
REZHAN HUSSEIN, MD, FACP, FIDSA's NPI is 1336169028 with credentials MD, FACP, FIDSA. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology